share_log

Cantor Fitzgerald Reiterates Overweight on Arcus Biosciences

Cantor Fitzgerald Reiterates Overweight on Arcus Biosciences

康泰菲瑞重新肯定对arcus biosciences的超重推荐
Benzinga ·  07/05 12:15

Cantor Fitzgerald analyst Alethia Young reiterates Arcus Biosciences (NYSE:RCUS) with a Overweight.

康泰菲茨杰拉德分析师Alethia Young重申arcus biosciences(纽交所:RCUS)的超配。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发